A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

by | Apr 20, 2026 | Clinical Trials | 0 comments

​ Conditions: Ankylosing Spondylitis

Interventions: Drug: HS_SW01 cells injection

Sponsors: Shenzhen Huishan Biotechnology Co., Ltd.; Southern Medical University, China

Not yet recruiting Conditions: Ankylosing Spondylitis
Interventions: Drug: HS_SW01 cells injection
Sponsors: Shenzhen Huishan Biotechnology Co., Ltd.; Southern Medical University, China
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *